ObsEva Company
ObsEva is a Swiss-based biopharmaceutical company that specializes in developing innovative drugs for women's reproductive medicine, with a main focus on therapies for preterm labor. The company was founded in 2012 by Ernest Loumaye and Andr\xe9 Chollet, both with extensive experience in the biopharmaceutical industry. ObsEva is a clinical-stage company that aims to develop and commercialize therapeutics for serious reproductive health and pregnancy conditions.
Investors
(INV)%20.jpg)
Total Funding:
$228,371,119
Headquarters:
Plan-les-ouates
Funding Status:
IPO
Employee Number:
1-10
Estimated Revenue:
$16. 32
Investment Stage:
N/A
Last Funding Type:
Post-IPO Debt
Number Of Exists:
Post-IPO Debt
Technology:
Longevity FemTech
Investor Type:
Company
Last Funding Date:
2019-08-08
Investors Number:
17
Founded Date:
2012
Industry:
Reproductive Health & Contraception